Once a waste product, squid visceral is now used to manufacture DHA-rich omega-3 products.
Squid is sold mostly for its tender little meats, but, beyond its arms and tentacles, squid offers plenty of oil. The oil can be used in dietary supplements, and if we’ve learned anything from krill oil, it’s that there’s plenty of room on the market for a fish oil alternative.
For squid oil to compete within the omega-3 market, manufacturers will need to distinguish squid from other marine sources. Fortunately, squid has several distinctions. At least in the case of Argentinian shortfin squid (Illex argentinus), the lifecycle of the animal is 12-14 months, meaning the population is constantly reproducing. This bodes well for sustainability, and so does the fact that squid oil can be sourced from preexisting squid fisheries.
“We harvest the oil from squid visceral,” says Michael Jeffers, CEO of squid oil supplier Helios Corp. (Santa Fe, NM). “The fisheries we work with-they were just throwing it overboard.”
Beyond the truly appealing fact that squid oil can be made from squid that are already being fished for food, squid oil has some unique scientific characteristics. Unlike krill and fish, which contain more EPA omega-3 than DHA omega-3, squid’s omega-3 ratio is reversed. The resulting oil can be tailored to DHA products, and, at least in the case of Helios’s ingredient, the oil is clear and crystalline in appearance and with little odor.
Another benefit to squid is that these animals appear to have a very low threat of mercury contamination. The Natural Resources Defense Council includes squid in its list of low-mercury seafoods.
While squid oil may conjure up images of monstrous cephalopods, calamari oil has exotic appeal and is grounded in a rather familiar seafood dish. Early launches of retail calamarioil suggest that calamari oil is a preferred marketing name.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.